Suggested Topics within your search.
Suggested Topics within your search.
- Immunologic Factors
- therapeutic use 8
- drug therapy 7
- Biological response modifiers 5
- Biological Products 4
- Cancer 4
- Neoplasms 4
- economics 4
- Biological Factors 3
- Biological products 3
- Cost-Benefit Analysis 3
- Immunotherapy 3
- Reagent Kits, Diagnostic 3
- Reference Standards 3
- Standards 3
- standards 3
- Antibodies, Monoclonal 2
- Antibodies, Monoclonal, Humanized 2
- Antineoplastic Agents 2
- Antineoplastic agents 2
- Chemical Actions and Uses 2
- Chemicals and Drugs 2
- Chemotherapy 2
- Disease 2
- Diseases 2
- Drugs 2
- Immunosuppressive Agents 2
- Insurance, Health, Reimbursement 2
- Pharmacologic Actions 2
- Therapeutic use 2
-
1
Extending Medicare Coverage for Preventive and Other Services.
Published 1999Full text (MCPHS users only)
Electronic eBook -
2
WHO Expert Committee on Biological Standardization : Sixty-third Report.
Published 2014Full text (MCPHS users only)
Electronic eBook -
3
The manufacture of medical and health products by transgenic plants
Published 2001Full text (MCPHS users only)
Electronic eBook -
4
Who Expert Committee on Biological Standardization : sixty-second report.
Published 2013Full text (MCPHS users only)
Electronic eBook -
5
-
6
WHO Expert Committee on Biological Standardization : sixtieth report
Published 2013Full text (MCPHS users only)
Electronic eBook -
7
Principles and practice of the biologic therapy of cancer
3rd ed.Published 2000Full text (MCPHS users only)
Electronic eBook -
8
Inflammatory diseases of blood vessels
2nd ed.Published 2012Full text (MCPHS users only)
Electronic eBook -
9
Cancer chemotherapy and biotherapy : principles and practice
5th ed.Published 2011Full text (MCPHS users only)
Electronic eBook -
10
Cancer chemotherapy and biotherapy : principles and practice
5th ed.Published 2011Full text (MCPHS users only)
Electronic eBook -
11
-
12
-
13
Pharmacoeconomic review report. Ocrelizumab (Ocrevus) (Hoffmann-La roche limited).
Published 2018Get full text
Full text
Electronic eBook -
14
-
15
Clinical review report. Dupilumab (Dupixent) (Sanofi genzyme, a division of Sanofi-Aventis Canada Inc.) : indication : indicated for the treatment of patients aged 12 years and old...
Version: Final.Published 2020Full text
Electronic eBook